| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2001 | WO2000033161A9 Methods to reduce variance in treatment studies using genotyping |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000018767A9 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1999061913A3 Improvements in or relating to diagnosis and treatment of bacterial infections |
| 04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 04/19/2001 | WO1998008546A8 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/19/2001 | US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 04/19/2001 | US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis |
| 04/19/2001 | US20010000341 Such as chronic bronchitis, compounds such as 4-(5-(4-(aminoiminomethyl)phenoxy)pentoxy)-2-hydroxy-N,N-bis-( 1-methylethyl)benzamide (Z)-2-butenedioate |
| 04/19/2001 | US20010000340 New uses for corticotropin releasing factor antagonists |
| 04/19/2001 | US20010000326 Extracting flowering top of Hypercium perforatum (St.-Johns-wort) with alcohol or acetone solvent, filtering, concetrating then diluting the extract with water or water-alcohol solvent, then extracting with aliphatic ester |
| 04/19/2001 | DE4244342C2 Benzofuranylimidazolderivate, Verfahren zur Herstellung und therapeutische Präparate, die dieselben enthalten Benzofuranylimidazolderivate, methods of preparation and therapeutic compositions containing the same |
| 04/19/2001 | DE19949897A1 Shaped article, e.g. in stick form, for controlled release of drugs in wounds or body cavities, comprising hydrophilic outer phase, lipophilic inner phase and drug, e.g. antibiotic |
| 04/19/2001 | DE19948417A1 Imidazol-Derivate und ihre Verwendung als Arzneimittel Imidazole derivatives and their use as medicaments |
| 04/19/2001 | DE19947373A1 Combination preparation comprising tocopherol and magnesium ascorbate for treatment and prevention of conditions resulting from oxidative stress |
| 04/19/2001 | DE19946737A1 Verwendung von Gangliosiden zur Modulation von Sphingolipid-Cholesterin-Mikrodomänen Use of gangliosides for the modulation of sphingolipid-cholesterol microdomains |
| 04/19/2001 | DE19946301A1 Antitumor agents and angiogenesis inhibitors having low neurotoxicity, comprise indole-3-glyoxylamide derivatives, are effective against resistant and metastasis-forming carcinomas |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2388232A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | CA2388053A1 Cationic dosper virosomes |
| 04/19/2001 | CA2387621A1 Extended release formulations of erythromycin derivatives |
| 04/19/2001 | CA2387439A1 Hop acids used to inhibit staphylococcus aureus |
| 04/19/2001 | CA2387353A1 Pharmaceutically active compounds |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387145A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386845A1 Polymorphic n-¬3-¬¬2-(3,4-dimethoxyphenyl) ethyl| amino| propyl| -4-nitro benzamide hydrochloride |
| 04/19/2001 | CA2386821A1 3-aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| 04/19/2001 | CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2386299A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | CA2386164A1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385123A1 Method of altering polypeptide aggregation |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2385071A1 Substituted pyrroles as antiproliferative agents for the treatment of cancer |
| 04/19/2001 | CA2383970A1 Topical nasal treatment using desloratadine |
| 04/19/2001 | CA2383650A1 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| 04/19/2001 | CA2382937A1 Anhydrous salt |
| 04/19/2001 | CA2382727A1 Methods of enhancing chemotherapy with the use of an imidazole |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/19/2001 | CA2381297A1 Pyrrolo¬2,3-d|pyrimidine nucleoside analogs |
| 04/19/2001 | CA2355357A1 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/19/2001 | CA2354558A1 Oral pharmaceutical composition |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092723A2 Bisphosphonic acid derivative and compound thereof labelled with radioactive nuclide |
| 04/18/2001 | EP1092721A1 Chiral glucosides and their use as chiral dopants for the production of cholesteric liquid crystalline compositions |
| 04/18/2001 | EP1092719A2 Imidazo[5,1-f][1,2,4]triazine derivatives |
| 04/18/2001 | EP1092718A1 2-(2-Alkoxy-5-heterocyclylsulphonylphenyl)purin-6-ones as phosphodiesterase inhibitors |
| 04/18/2001 | EP1092717A2 Polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092716A2 Derivatives of benzothiophenes, benzofurans and indoles, method for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same |
| 04/18/2001 | EP1092437A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 04/18/2001 | EP1092435A1 Remedies for diabetes |
| 04/18/2001 | EP1092434A1 Novel composition containing lansoprazole and process for its preparation |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1092432A1 Anti-ischemic compounds |
| 04/18/2001 | EP1092431A2 Lasofoxifene compositions |
| 04/18/2001 | EP1092430A1 Non-chlorofluorocarbon aerosol formulations |
| 04/18/2001 | EP1092429A1 Pharmaceutical preparations for drugs of low solubility |
| 04/18/2001 | EP1092426A1 Use of inorganic-organic complexes whitin a composition |
| 04/18/2001 | EP1092423A2 Use of DHEA or its precursors and metabolites as skin depigmentation agents |
| 04/18/2001 | EP1092352A2 Microbial oil mixtures and uses thereof |
| 04/18/2001 | EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 04/18/2001 | EP1091978A2 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 04/18/2001 | EP1091974A2 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 04/18/2001 | EP1091971A2 Polyketides and their synthesis |
| 04/18/2001 | EP1091970A1 Method for preparing aloin by extraction |
| 04/18/2001 | EP1091962A1 Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 04/18/2001 | EP1091960A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents |
| 04/18/2001 | EP1091959A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament |
| 04/18/2001 | EP1091958A1 Salts of paroxetine |
| 04/18/2001 | EP1091957A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
| 04/18/2001 | EP1091956A1 Muscarinic antagonists |
| 04/18/2001 | EP1091955A1 Quinolones as serine protease inhibitors |
| 04/18/2001 | EP1091954A1 Process for producing (8- chloro-3,10- dibromo-6,11- dihydro- 5h-benzo 5,6]cyclohepta 1,2-b]pyridin-11-yl)- 1-piperidine |
| 04/18/2001 | EP1091953A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 04/18/2001 | EP1091951A1 Novel polyoxypropylenepolyoxyethylene vitamin e and preparation thereof |
| 04/18/2001 | EP1091950A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 04/18/2001 | EP1091949A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 04/18/2001 | EP1091948A2 Tubulin binding compounds (cobra) |
| 04/18/2001 | EP1091947A1 Alpha-(1-piperazinyl)acetamido arenecarboxylic acid derivatives as antidiabetic agents |
| 04/18/2001 | EP1091946A1 New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP1091938A2 Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | EP1091936A2 Method for making hydroxy-25-ene-vitamin d compounds |
| 04/18/2001 | EP1091934A2 Alkyl ketones as potent anti-cancer agents |
| 04/18/2001 | EP1091933A1 SUBSTITUTED $g(b)-DIKETONES AND THEIR USE |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP1091928A1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 04/18/2001 | EP1091924A1 Novel retinoids and use thereof |
| 04/18/2001 | EP1091760A1 Pharmaceutical composition containing an ester or amide pla2 inhibitor |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091745A1 Treatment of hyperproliferative disorders |